Русский
Bendopnea and global left ventricular function index as possible factors for prediction of mortality in patients with chronic heart failure
DOI: https://dx.doi.org/10.18565/therapy.2022.9.60-67
Larina V.N., Lunev V.I.
N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia, Moscow
The aim of the study was to evaluate the correlation and prognostic value of LVGFI and bendopnea in outpatients with CHF aged 60 years and older.
Material and methods. The study included 55 outpatients with CHF II–IV FC: 25 persons with bendopnea (64% of male patients) aged 75 (66; 79) years (main group) and 30 people without bendopnea (23% of male patients) aged 76 (73,5; 79) years (comparison group). LVGFI (%) was calculated by the following formula: LV/ [0.5 × (LV EDV + LV ESV) + LV myocardial mass/ 1.05] × 100. The follow-up period was 36 (24; 36) months.
Results. LVGFI in the main group consisted 18,5 (16,6; 21,3)%, in the comparison group - 21.4 (19,5; 22,7)% (p=0.011). LVGFI correlated with bendopnea (r=-0,35, p=0,010), CHF FC(r=-0,52, p <0,001), N-terminal proBNP (r=-0,52, p=0,015), a history of myocardial infarction in anamnesis (r=-0,28, p=0,040). In its turn, bendopnea correlated with FC CHF (r=0,82, p <0,001) and N-terminal proBNP (r=0,54, p=0,012). The development of bendopnea is most likely in patients with LVGFI ≤20,5% (AUC 0,70±0,07; 95% CI: 0,56–0,84; p=0.011; sensitivity 64,0%, specificity 63,3%; OR 3,07; 95% CI: 1,02–9,26; p <0,05). The value of LVGFI for predicting death was ≤19,2% (AUC 0,79±0,07; 95% CI: 0,65–0,93; p=0.002; sensitivity 75,0%, specificity 74,4%). Multiple regression analysis revealed an association of bendopnea and death in patients with LVGFI ≤19,2% (R2=0,446; sensitivity 88,4%, specificity 75%). For the cohort of patients with bendopnea and LVGFI ≤19.2%, the RR was 2,2 (95% CI: 1,15–4,20; p<0.05).
Conclusion. The combination of bendopnea and LVGFI ≤19,2% reflects the severity of clinical condition, significant remodeling of the left ventricular myocardium, and with a high probability can predict a lethal outcome in the group of CHF elderly patients.
Literature
1. Savarese G., Becher P.M., Lund L.H. et al. Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc Res. 2022: cvac013. https://dx.doi.org/10.1093/cvr/cvac013. Online ahead of print.
2. Seferovic P.M., Vardas P., Jankowska E.A. et al. The Heart Failure Association Atlas: Heart failure epidemiology and management statistics 2019. Eur J Heart Fail. 2021; 23(6): 906–14. https://dx.doi.org/10.1002/ejhf.2143.
3. Бойцов С.А. Хроническая сердечная недостаточность: эволюция этиологии, распространенности и смертности за последние 20 лет. Терапевтический архив. 2022; 94(1): 5–8. [Boytsov S.A. Chronic heart failure: evolution of etiology, prevalence and mortality over the past 20 years. Terapevticheskiy arkhiv = Therapeutic Archive. 2022; 94(1): 5–8 (In Russ.)].https://dx.doi.org/10.26442/00403660.2022.01.201317. EDN: HRWCBS.
4. Thibodeau J.T., Jenny B.E., Maduka J.O. et al. Bendopnea and risk of adverse clinical outcomes in ambulatory patients with systolic heart failure. Am Heart J. 2017; 183: 102–7. https://dx.doi.org/10.1016/j.ahj.2016.09.011.
5. Mewton N., Opdahl A., Choi E.Y.et al. Left ventricular global function index by magnetic resonance imaging--a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: The multi-ethnic study of atherosclerosis. Hypertension. 2013; 61(4): 770–78. https://dx.doi.org/10.1161/HYPERTENSIONAHA.111.198028.
6. Мареев В.Ю., Фомин И.В., Агеев Ф.Т. с соавт. Клинические рекомендации ОССН – РКО – РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. Кардиология. 2018; 58(6S): 8–158. [Fomin I.V., Ageev F.T. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiya = Cardiology. 2018; 58(6S): 8–158 (In Russ.)]. https://dx.doi.org/10.18087/cardio.2475. EDN: XUAREL.
7. Lang R.M., Badano L.P., Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1): 1–39.e14. https://dx.doi.org/10.1016/j.echo.2014.10.003.
8. Шиллер Н., Осипов М.А. Клиническая эхокардиография. 2-е изд. М.: Практика. 2005; 344 с. [Schiller N., Osipov M.A. Clinical echocardiography. 2nd edition. Moscow: Praktika = Practice. 2005; 344 pp. (In Russ.)]. ISBN: 589816049-3.
9. Savarese G., Stolfo D., Sinagra G., Lund L.H. Heart failure with mid-range or mildly reduced ejection fraction. Nat Rev Cardiol. 2022; 19(2): 100–16. https://dx.doi.org/10.1038/s41569-021-00605-5.
10. Nwabuo C.C., Moreira H.T., Vasconcellos H.D. et al. Left ventricular global function index predicts incident heart failure and cardiovascular disease in young adults: the coronary artery risk development in young adults (CARDIA) study. Eur Heart J Cardiovasc Imaging. 2019; 20(5): 533–40. https://dx.doi.org/10.1093/ehjci/jey123.
11. Eitel I., Poss J., Jobs A. et al. Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2015; 17(1): 62.https://dx.doi.org/10.1186/s12968-015-0161-x.
12. Reinstadler S.J., Klug G., Feistritzer H.J. et al. Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction. Eur Heart J Cardiovasc Imaging. 2016; 17(2): 169–76. https://dx.doi.org/10.1093/ehjci/jev129.
13. Pezel T., Besseyre des Horts T., Schaaf M. et al. Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study. Arch Cardiovasc Dis. 2020; 113(11): 710–20. https://dx.doi.org/10.1016/j.acvd.2020.05.024.
14. Капустина А.Ю., Минушкина Л.О., Алехин М.Н. с соавт. Индекс глобальной функции левого желудочка в качестве прогностического фактора сердечно-сосудистых осложнений у пациентов с острым коронарным синдромом. Кардиология. 2021; 61(8): 23–31. [Kapustina A.Yu., Minushkina L.O., Alekhin M.N. et al. Left ventricular global function index as a predictor of adverse cardiovascular events in patients with acute coronary syndrome. Kardiologiya = Cardiology. 2021; 61(8): 23–31 (In Russ.)].https://dx.doi.org/10.18087/cardio.2021.8.n1508. EDN: INABST.
15. Ларина В.Н., Лунев В.И., Алехин М.Н. Индекс глобальной функции левого желудочка: прогностическое значение у пациентов с хронической сердечной недостаточностью в возрасте 60 лет и старше. Кардиоваскулярная терапия и профилактика. 2020; 19(5): 2404. [Larina V.N., Lunev V.I., Alekhin M.N. Left ventricular global function index: prognostic value in patients with heart failure aged 60 years and older. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2020; 19(5): 2404 (In Russ.)]. https://dx.doi.org/10.15829/1728-8800-2020-2404. EDN: MMBBST.
16. Ларина В.Н., Лунев В.И., Ларин В.Г. с соавт. Прогнозирование течения сердечной недостаточности у пациентов старшего возраста с хронической болезнью почек. Терапия. 2021; 7(9): 85–94. [Larina V.N., Lunev V.I., Larin V.G. et al. Predicting the course of heart failure in older patients with chronic kidney disease. Terapiya = Therapy. 2021; 7(9): 85–94 (In Russ.)].https://dx.doi.org/10.18565/therapy.2021.9.85-94. EDN: HFKASL.
17. Larina V.N., Poryadin G.V., Bogush N.L. et al. Clinical profile of elderly patients with chronic heart failure and bendopnea. Pol Arch Intern Med. 2019; 129(12): 939–941. https://dx.doi.org/10.20452/pamw.15016.
18. Baeza-Trinidad R., Mosquera-Lozano J.D., El Bikri L. Assessment of bendopnea impact on decompensated heart failure. Eur J Heart Fail. 2017; 19(1): 111–15. https://dx.doi.org/10.1002/ejhf.610.
19. Pranata R., Yonas E., Chintya V. et al. Clinical significance of bendopnea in heart failure-Systematic review and meta-analysis. Indian Heart J. 2019; 71(3): 277–83. https://dx.doi.org/10.1016/j.ihj.2019.05.001.
20. Ларина В.Н., Барт Б.Я., Чукаева Н.И. с соавт. Одышка при наклоне вперед: связь с эхокардиографическими параметрами и клиническими исходами у пациентов пожилого возраста с хронической сердечной недостаточностью. Кардиология. 2018; 58(12): 36–44. [Larina V.N., Bart B.Y., Chukaeva I.I. et al. Bendopnea: association with echocardiographic features and clinical outcomes in elderly patients with chronic heart failure. Kardiologiya = Cardiology. 2018; 58(12): 36–44 (In Russ.)].https://dx.doi.org/10.18087/cardio.2018.12.10190. EDN: VOWJJY.
21. Karauzum K., Karauzum I., Kilic T. et al. Bendopnea and its clinical importance in outpatient patients with pulmonary arterial hypertension. Acta Cardiol Sin. 2018; 34(6): 518–25. https://dx.doi.org/10.6515/ACS.201811_34(6).20180528A.
22. Гасанова А.Д., Драгунов Д.О., Соколова А.В., Арутюнов Г.П. Оценка риска развития тяжелых сердечно-сосудистых осложнений у пациентов с хронической сердечной недостаточностью с сохраненной и промежуточной фракцией выброса при наличии симптома бендопноэ. Кардиология. 2020; 60(4): 48–53. [Gasanova A.D., Dragunov D.O., Sokolova A.V., Arutyunov G.P. Risk assessment of development of the major adverse cardiac events in patients with chronic heart failure with a preserved and intermediate ejection fraction in the presence of a bendopnea symptom. Kardiologiya = Cardiology. 2020; 60(4): 48–53. (In Russ.)].https://dx.doi.org/10.18087/cardio.2020.4.n1043. EDN: MERUPI.
23. Драгунов Д.О., Соколова А.В., Гасанова А.Д. с соавт. Бендопноэ как фактор риска заболеваемости COVID-19 у пациентов с ХСН. Здоровье мегаполиса. 2021; 2(2): 26–34. [Dragunov D.O., Sokolova A.V., Gasanova A.D. et al. Bendopnea as a risk factor for the incidence of COVID-19 in patients with CHF. Zdorov'e megapolisa = City Healthсare. 2021; 2(2): 26–34 (In Russ.)].https://dx.doi.org/10.47619/2713-2617.zm.2021.v2i2;26-34. EDN: EWEPWQ.
About the Autors
Vera N. Larina, Dr. med. habil., professor, head of the Department of polyclinic therapy of the Faculty of general medicine, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. Address: 117997, Moscow, 1 Ostrovityanova Str. E-mail: larinav@mail.ru.
ORCID: https://orcid.org/0000-0001-7825-5597. eLibrary SPIN: 3674-9620
Viktor I. Lunev, assistant at the Department of polyclinic therapy of the Faculty of general medicine, N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia. Address: 117997, Moscow, 1 Ostrovityanova Str. E-mail: sandvit@ya.ru. ORCID: https://orcid.org/0000-0001-9002-7749. eLibrary SPIN: 6618-7536
Similar Articles
